Works matching IS 18696953 AND DT 2017 AND VI 8 AND IP 5


Results: 23
    1
    2
    3
    4
    5
    6
    7
    8

    Possible Long-Term Efficacy of Sitagliptin, a Dipeptidyl Peptidase-4 Inhibitor, for Slowly Progressive Type 1 Diabetes (SPIDDM) in the Stage of Non-Insulin-Dependency: An Open-Label Randomized Controlled Pilot Trial (SPAN-S).

    Published in:
    Diabetes Therapy, 2017, v. 8, n. 5, p. 1123, doi. 10.1007/s13300-017-0299-7
    By:
    • Takuya Awata;
    • Akira Shimada;
    • Taro Maruyama;
    • Yoichi Oikawa;
    • Nobuyuki Yasukawa;
    • Susumu Kurihara;
    • Yumi Miyashita;
    • Masako Hatano;
    • Yuichi Ikegami;
    • Masafumi Matsuda;
    • Masataka Niwa;
    • Youichiro Kazama;
    • Shoichiro Tanaka;
    • Tetsuro Kobayashi
    Publication type:
    Article
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18

    Rationale, Design, and Baseline Characteristics of the Utopia Trial for Preventing Diabetic Atherosclerosis Using an SGLT2 Inhibitor: A Prospective, Randomized, Open-Label, Parallel-Group Comparative Study.

    Published in:
    Diabetes Therapy, 2017, v. 8, n. 5, p. 999, doi. 10.1007/s13300-017-0292-1
    By:
    • Naoto Katakami;
    • Tomoya Mita;
    • Hidenori Yoshii;
    • Toshihiko Shiraiwa;
    • Tetsuyuki Yasuda;
    • Yosuke Okada;
    • Yutaka Umayahara;
    • Hideaki Kaneto;
    • Takeshi Osonoi;
    • Tsunehiko Yamamoto;
    • Nobuichi Kuribayashi;
    • Kazuhisa Maeda;
    • Hiroki Yokoyama;
    • Keisuke Kosugi;
    • Kentaro Ohtoshi;
    • Isao Hayashi;
    • Satoru Sumitani;
    • Mamiko Tsugawa;
    • Makoto Ohashi;
    • Hideki Taki
    Publication type:
    Article
    19
    20
    21
    23